NCT02399449View on ClinicalTrials.gov

IV Iron Safety: Evaluation of Iron Species in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

March 22, 2019

Study Completion Date

April 25, 2019

Conditions
Anemia
Interventions
DRUG

Brand sodium ferric gluconate

brand product

DRUG

Generic sodium ferric gluconate

generic product

Trial Locations (1)

21201

University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT02399449 - IV Iron Safety: Evaluation of Iron Species in Healthy Subjects | Biotech Hunter | Biotech Hunter